Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dendritic/Leukemic Fusion Cell Vaccine Therapy For AML Patients In First Remission; A Phase I Clinical Trial

NCT00100971 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT00100971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00100971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dendritic/Leukemic Fusion Cell Vaccine Therapy For AML Patients In First Remission; A Phase I Clinical Trial
Lead sponsor
Boston Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2004
Completion date
March 31, 2007
Enrollment
9
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia